Seminars in Hematology
Volume 41, Issue 3 , Pages 234-245, July 2004

Advances in the use of monoclonal antibodies in the therapy of chronic lymphocytic leukemia☆

  • Jeanette Lundin

      Affiliations

    • Departments of Hematology/Oncology, Karolinska University Hospital, Stockholm, Sweden
    • Corresponding Author InformationAddress correspondence to Jeanette Lundin, MD, PhD, Department of Oncology, Karolinska Hospital, SE-171 76 Stockholm, Sweden
    • ,
  • Anders Österborg

      Affiliations

    • Departments of Hematology/Oncology, Karolinska University Hospital, Stockholm, Sweden

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported in part by the Swedish Cancer Society, the Cancer Society in Stockholm, and the Karolinska Institutet Foundations.

PII: S0037-1963(04)00092-7

doi:10.1053/j.seminhematol.2004.05.005

Seminars in Hematology
Volume 41, Issue 3 , Pages 234-245, July 2004

Article Tools